Last reviewed · How we verify
Matching Placebo to JNJ-77242113 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Matching Placebo to JNJ-77242113 (Matching Placebo to JNJ-77242113) — Janssen Research & Development, LLC. This is a placebo control formulation matching the inactive vehicle and appearance of JNJ-77242113 for blinded clinical trial comparison.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching Placebo to JNJ-77242113 TARGET | Matching Placebo to JNJ-77242113 | Janssen Research & Development, LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching Placebo to JNJ-77242113 CI watch — RSS
- Matching Placebo to JNJ-77242113 CI watch — Atom
- Matching Placebo to JNJ-77242113 CI watch — JSON
- Matching Placebo to JNJ-77242113 alone — RSS
Cite this brief
Drug Landscape (2026). Matching Placebo to JNJ-77242113 — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-to-jnj-77242113. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab